Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PharmOutcomes’ owner to be sold to Optum UK under £1.24bn deal

Health services company Optum UK has agreed to buy healthcare software and systems provider EMIS Group, which owns the PharmOutcomes platform, in a deal worth over £1 billion.


Bordeaux UK Holdings II Limited – an affiliate of Optum UK and part of US healthcare and insurance company UnitedHealth Group – agreed to buy EMIS Group for a cool £1.24 billion, the companies revealed last week (June 17).

The news of EMIS’ acquisition – which is expected to go through before the end of this year – comes just over two years since the software provider announced it had acquired PharmOutcomes’ previous owner, Pinnacle Health Partnership and Pinnacle Systems Management.

PharmOutcomes is used in about 85% of pharmacies in England, a spokesperson told C+D today (June 20).


No changes to UK operations


Commenting on the acquisition, Optum UK pledged to ensure the “continuity of EMIS’s existing business”.

The company's headquarters are expected to remain in Leeds, with “no material changes to its existing operations and locations”.

Optum UK does not anticipate changes to the overall headcount or “conditions of employment” at EMIS within the first year of the acquisition, it said.

C+D recently revealed that 9,122 pharmacies selected PharmOutcomes to provide the Community Pharmacist Consultation Service. 

“Optum UK and its affiliates have been present in the UK for nearly 20 years, seeking to support the NHS and its people in their mission,” the companies wrote in a statement announcing the deal.

Meanwhile, EMIS CEO Andy Thorburn said that access to “UnitedHealth Group’s resources and expertise will enable us to accelerate our development”.


Related Content


Pharmacist Manager
East Kilbride, Glasgow
£45,000 - £55,000

Apply Now
Latest News & Analysis



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts